COVID-19 test kit CoV-SCAN

IgGIgMfor antigens

BioMedomics has launched the CoV-SCAN Rapid Antigen Test (CoV-SCAN) to aid in the diagnosis of active coronavirus infection. The test detects the N-protein antigen of SARS-CoV-2 using a novel double antibody sandwich assay format. It uses a panel of antibodies, targeting multiple antigenic sites on SARS-CoV-2 N-protein antigen, that can detect many new variants of concern at equivalent (or up to eight-fold) improved sensitivity compared to original isolate. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel beta coronavirus and is the causative agent of Coronavirus Disease 2019 (COVID-19) and the pandemic. SARS-CoV-2 is mainly transmitted through droplets and contact routes, and people who are infected with SARS-CoV-2 may express signs and symptoms of acute respiratory illness, such as fever, cough, shortness of breath, etc., but can also be asymptomatic. In March of 2020, BioMedomics successfully created one of the most reliable, accurate, and fastest COVID-19 antibody tests in the world: the COVID-19 IgM/IgG Rapid Antibody Test. BioMedomics has continued to put their passion of developing fast, accurate, and reliable COVID-19 testing methods into the new CoV-SCAN Rapid Antigen Test. While PCR tests take days to reveal results and require complex and expensive equipment, Features & Benefits BioMedomics’s CoV-SCAN helps in detection of extracted nucleocapsid protein (N-protein) antigens specific to SARS-CoV-2 in nasal swab specimens directly collected from individuals who are suspected of COVID-19 by a healthcare provider within the first five (5) days of symptom onset.